StockNews.com upgraded shares of Aspira Women’s Health (NASDAQ:AWH – Free Report) from a sell rating to a hold rating in a research note published on Wednesday.
Aspira Women’s Health Trading Down 3.6 %
AWH opened at $1.06 on Wednesday. The stock’s 50 day simple moving average is $1.39 and its 200-day simple moving average is $2.74. Aspira Women’s Health has a 1 year low of $0.86 and a 1 year high of $6.75. The stock has a market cap of $17.02 million, a PE ratio of -0.73 and a beta of 1.54.
Aspira Women’s Health (NASDAQ:AWH – Get Free Report) last announced its quarterly earnings results on Monday, August 12th. The company reported ($0.28) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.32) by $0.04. The company had revenue of $2.42 million during the quarter, compared to the consensus estimate of $2.60 million. During the same quarter last year, the company earned ($0.28) earnings per share. Equities analysts forecast that Aspira Women’s Health will post -1.29 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Aspira Women’s Health
About Aspira Women’s Health
Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.
Featured Stories
- Five stocks we like better than Aspira Women’s Health
- Best Stocks Under $10.00
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- There Are Different Types of Stock To Invest In
- MarketBeat Week in Review – 8/12 – 8/16
- How to Evaluate a Stock Before Buying
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.